Photo credit: MSF/Alexandra Sadokova Press release Press release | 16 January 2023 Tuberculosis India India must reject Johnson & Johnson’s attempt to extend monopoly on lifesaving TB drug bedaquiline 4 min
Photograph by Alexandra Sadokova Press release Press release | 22 December 2022 Tuberculosis TB-PRACTECAL: Groundbreaking MSF trial finds better treatment for people with drug-resistant tuberculosis
Photo credit: Oksana Parafeniuk/MSF Press release Press release | 15 December 2022 Tuberculosis MSF responds to groundbreaking updated WHO guidelines for drug-resistant tuberculosis 3 min
Photograph by Albert Masias Press release Press release | 29 November 2022 HIV/AIDS Pharmaceutical corporation ViiV must make ground-breaking HIV prevention injection affordable and available 5 min
Prem Hessenkamp Press release Press release | 08 November 2022 Tuberculosis New MSF report warns that major opportunity to increase access to newer, safer DR-TB drugs is at risk 6 min
Photograph by Atul Loke Press release Press release | 02 November 2022 Intellectual property and trade United KingdomIndia MSF responds to UK's disastrous proposal on intellectual property in UK-India Free Trade Agreement 3 min
Photograph by Atul Loke Press release Press release | 27 October 2022 Tuberculosis MSF responds to WHO Global TB Report 2022, calls for scale up of shorter and safer DR-TB treatments to help save more lives 4 min
Photograph by Alexandre Marcou Press release Press release | 19 October 2022 Tropical & neglected diseases MSF responds to change in global cholera vaccine strategy amid unprecedented number of outbreaks 3 min
